
How Insurers Will Value Healthcare AI
The battle for medical AI adoption is no longer about clearing regulatory hurdles; it is about getting paid.
Discover the newest research about AI innovations in 🤖 Machine Learning.

The battle for medical AI adoption is no longer about clearing regulatory hurdles; it is about getting paid.

Regulators are shifting from paper-based approvals to live-fire testing in actual clinics.

A new deep learning model turns cheap, blurry brain scans into high-contrast maps, helping doctors spot stroke damage faster and agree on treatment.

Hospitals are drowning in imaging volumes, but buying new CT scanners to improve image quality is a financial non-starter for most struggling health systems.

A new wireless handheld AI system allows novice doctors to screen infants for hip dysplasia with expert-level accuracy.

Regulators are finally letting AI predict drug safety before human trials, signaling a massive shift away from traditional animal testing.

A massive new study shows AI can spot cardiovascular danger on routine mammograms, but the technology faces a major reality check when compared to standard clinical risk calculators.

A massive cash injection into Canada’s health data infrastructure highlights the growing shift toward federated AI, but technology alone cannot solve deep-seated jurisdictional friction.

A new study reveals that neurologists struggle to accurately predict stroke recovery because of systematic optimism and poor visual assessments, but AI models can correct these human errors.

The regulatory bottleneck for AI in drug development is finally beginning to crack.